Table 1.
Patients’ characteristics
| Characteristics | N (%) |
|---|---|
| Age at transplantation, years | |
| Median (range) | 57 (20–70) |
| 16–54 years | 17 (45) |
| ≥ 55 years | 21 (55) |
| Male sex | 19 (50) |
| Underlying disease | |
| Acute myeloid leukemia | 15 (39) |
| Myelodysplastic syndrome | 5 (13) |
| Chronic myeloid leukemia | 1 (2.6) |
| T-cell large granular lymphocytic leukemia | 1 (2.6) |
| Adult T-cell leukemia | 1 (2.6) |
| Malignant lymphoma | 6 (16) |
| Multiple myeloma | 1 (2.6) |
| Disease phase at transplantation | |
| Early | 17 (45) |
| Non-early | 21 (55) |
| Preconditioning regimen | |
| MAC | 21 (55) |
| RIC | 17 (45) |
| TBI in preconditioning | |
| 0 | 13 (34) |
| 1–8 Gy | 15 (39) |
| > 8 Gy | 10 (26) |
| HLA disparities | |
| 0 | 2 (5.3) |
| 1 | 10 (26) |
| 2 | 26 (68) |
| CNS involvement of underlying disease | |
| None | 36 (95) |
| History | 2 (5.3) |
| At the time of transplantation | 0 (0) |
| Mental illness | |
| History | 1 (2.6)a |
| At the start of preconditioning | 1 (2.6)b |
MAC myeloablative conditioning, RIC reduced-intensity conditioning, TBI total body irradiation, HLA human leukocyte antigen, CNS central nervous system
aDepression
bAdjustment disorder